0.9300USD+9.26%Mkt Cap: 11.91M USDP/E: —Last update: 2026-06-01
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL l…
Industry Peers
Drug Manufacturers - Specialty & Generic150.78BSEKP/E 166.4
58.93BTRY—
56.89BEURP/E 22.4
32.78BPLNP/E 21.4
23.20BUSDP/E 20.2
18.39BUSD—
16.21BUSDP/E 24.8
13.00BTRY—
Indicators:|
Key Statistics
Company
Market Cap11.91M USD
Enterprise Value11.75M USD
Revenue (TTM)43.20M USD
Gross Profit30.74M USD
Net Income (TTM)-10.54M USD
Revenue/Share3.973 USD
Last Price0.9300 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees84
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)2.77
PEG—
EV/EBITDA-1.11
EV/Revenue0.27
P/S0.26
P/B1.70
EPS (TTM)-0.98
EPS (Forward)0.32
52W Range
0.536060% of range1.190
52W High1.190 USD
52W Low0.5360 USD
Profitability
Gross Margin73.71%
Oper. Margin-38.95%
EBITDA Margin-24.45%
Profit Margin-25.26%
ROE-100.53%
ROA-36.89%
Growth
Revenue Growth17.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-13.36M USD
CapEx (TTM)2.00K USD
FCF Margin3.42%
FCF Yield12.40%
Net Debt1.40M USD
Net Debt/EBITDA-0.13
Balance Sheet
Debt/Equity0.59
Current Ratio1.21
Quick Ratio0.99
Book Value/Sh0.5200 USD
Cash/Share0.5410 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:20
Split DateJul 5, 2023
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)5.875 USD
Target Range2.750 USD – 9.000 USD
# Analysts2
Ownership
Shares Out.12.80M
Float8.06M
Insiders12.84%
Institutions22.75%
Short Interest
Short Ratio0.4d
Short % Float0.69%
Short % Out.0.66%
Shares Short84.40K
Short (prev mo.)72.50K
Technical
SMA 500.9700 (-4.1%)
SMA 2000.9100 (+2.2%)
Beta0.91
S&P 52W Chg27.94%
Avg Vol (30d)213.72K
Avg Vol (10d)284.09K
Technical Indicators
RSI (14)40.1
MACD-0.0587
MACD Signal-0.0472
MACD Hist.-0.0115
BB Upper1.246 USD
BB Middle0.9477 USD
BB Lower0.6497 USD
BB Width62.89%
ATR (14)0.0697 USD
Vol Ratio (20d)0.14x